Ueno, Masanobu
Miyagawa, Ippei
Aritomi, Takafumi
Kimura, Koichi
Iwata, Shigeru
Hanami, Kentaro
Fukuyo, Syunsuke
Kubo, Satoshi
Miyazaki, Yusuke
Nakayamada, Shingo
Tanaka, Yoshiya
Funding for this research was provided by:
University of Occupational and Environmental Health, Japan and UOEH Grant for Advanced Research
Article History
Received: 13 November 2021
Accepted: 13 June 2022
First Online: 29 June 2022
Declarations
:
: Ethical approval was obtained from the University of Occupational and Environmental Health, Japan Ethics Committee following the Helsinki Declaration. This retrospective study was approved by the institutional review board, and the requirement to obtain informed consent was waived.
: Not applicable.
: Y. Tanaka has received speaking fees and/or honoraria from Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi-kasei, GSK, Mitsubishi-Tanabe, Gilead, and Janssen; research grants from Abbvie, Mitsubishi-Tanabe, Chugai, Asahi-Kasei, Eisai, Takeda, and Daiichi-Sankyo; and consultant fee from Eli Lilly, Daiichi-Sankyo, Taisho, Ayumi, Sanofi, GSK, and Abbvie.S. Nakayamada has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers, Pfizer, GlaxoSmithKline, Sanofi, Chugai, Astellas, Asahi-kasei, and Boehringer Ingelheim and has received research grants from Mitsubishi-Tanabe, Novartis, and MSD.